Európai Unió -
izlandi -
EMA (European Medicines Agency)
hemgenix
csl behring gmbh - etranacogene dezaparvovec - hemophilia b - other hematological agents - treatment of severe and moderately severe haemophilia b (congenital factor ix deficiency) in adult patients without a history of factor ix inhibitors.
Izland -
izlandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
ciprofloxacin alvogen (ciprofloxacin portfarma) filmuhúðuð tafla 500 mg
alvogen ehf. - ciprofloxacinum hýdróklóríð - filmuhúðuð tafla - 500 mg
Izland -
izlandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
ciprofloxacin alvogen (ciprofloxacin portfarma) filmuhúðuð tafla 250 mg
alvogen ehf. - ciprofloxacinum hýdróklóríð - filmuhúðuð tafla - 250 mg
Izland -
izlandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
peratsin húðuð tafla 2 mg
orion corporation - perphenazinum inn - húðuð tafla - 2 mg
Izland -
izlandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
ciprofloxacin navamedic (ciprofloxacin villerton) innrennslislyf, lausn 2 mg/ml
navamedic asa - ciprofloxacinum laktat - innrennslislyf, lausn - 2 mg/ml
Izland -
izlandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
florinef tafla 0,1 mg
viatris aps - fludrocortisonum acetat - tafla - 0,1 mg
Izland -
izlandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
latanoprost actavis augndropar, lausn 50 míkróg/ml
actavis group ptc ehf. - latanoprostum inn - augndropar, lausn - 50 míkróg/ml
Izland -
izlandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
myfortic magasýruþolin tafla 180 mg
novartis healthcare a/s - mycophenolatum natríum - magasýruþolin tafla - 180 mg
Izland -
izlandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
myfortic magasýruþolin tafla 360 mg
novartis healthcare a/s - mycophenolatum natríum - magasýruþolin tafla - 360 mg
Izland -
izlandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
mykofenolatmofetil actavis filmuhúðuð tafla 500 mg
actavis group ptc ehf. - mycophenolatum mofetil - filmuhúðuð tafla - 500 mg